Javascript must be enabled to continue!
Calciphylaxis after parathyroidectomy
View through CrossRef
AbstractA 60‐year‐old African American man with end stage renal disease on hemodialysis (HD) for the past 2.5 years developed severe hyperparathyroidism. Other past medical history included atrial fibrillation, type II diabetes mellitus, hypertension, gout, pericardial effusion needing pericardial window, deep vein thrombosis, mitral insufficiency, and cardiomyopathy with implantable cardioversion device placement. His parathyroid hormone (PTH) level peaked at 4,191 pg/mL despite being on cinacalcet, sevelamer, and paricalcitol. He underwent a subtotal parathyroidectomy in January 2015, after which his PTH levels dropped to 184 pg/mL. Approximately 4 weeks later he developed extensive, painful necrotic skin lesions in both his lower extremities and buttocks, suggestive of calciphylaxis which was confirmed by tissue biopsy. The patient was treated with elaborate wound care, wound debridements, increased dialysis dose, and IV sodium thiosulfate (STS) during hemodialysis. Besides STS, he was treated with narcotics, gabapentin, topical lidocaine on intact skin, and oral steroids for pain control. Even though his lesions improved initially, he deteriorated due to recurrent sepsis, respiratory failure, and prolonged hospitalization which culminated in stopping dialysis before he passed away. Calciphylaxis, or calcific uremic arteriolopathy, is a life‐threatening complication of end stage renal disease. Treatment of this condition is multidisciplinary which includes elaborate wound care, increasing dialysis dose, and discontinuing vitamin D supplements and calcium containing phosphate binders. Even though STS has been recommended off‐label, several studies have shown promising results with resolution of lesions. Thus, sodium thiosulfate has become the mainstay of treatment. Parathyroidectomy is a recommended modality of treatment in those with high PTH levels. Our case was unique in that calciphylaxis developed after subtotal parathyroidectomy. We believe that this is due to a decreased PTH level and decreasing bone turnover which resulted in more circulating calcium facilitating vascular and soft tissue calcification. The exact mechanism of developing calciphylaxis after parathyroidectomy is unknown. Even though parathyroidectomy is an effective treatment for calciphylaxis, clinicians should be aware that it can rarely present after parathyroidectomy.
Title: Calciphylaxis after parathyroidectomy
Description:
AbstractA 60‐year‐old African American man with end stage renal disease on hemodialysis (HD) for the past 2.
5 years developed severe hyperparathyroidism.
Other past medical history included atrial fibrillation, type II diabetes mellitus, hypertension, gout, pericardial effusion needing pericardial window, deep vein thrombosis, mitral insufficiency, and cardiomyopathy with implantable cardioversion device placement.
His parathyroid hormone (PTH) level peaked at 4,191 pg/mL despite being on cinacalcet, sevelamer, and paricalcitol.
He underwent a subtotal parathyroidectomy in January 2015, after which his PTH levels dropped to 184 pg/mL.
Approximately 4 weeks later he developed extensive, painful necrotic skin lesions in both his lower extremities and buttocks, suggestive of calciphylaxis which was confirmed by tissue biopsy.
The patient was treated with elaborate wound care, wound debridements, increased dialysis dose, and IV sodium thiosulfate (STS) during hemodialysis.
Besides STS, he was treated with narcotics, gabapentin, topical lidocaine on intact skin, and oral steroids for pain control.
Even though his lesions improved initially, he deteriorated due to recurrent sepsis, respiratory failure, and prolonged hospitalization which culminated in stopping dialysis before he passed away.
Calciphylaxis, or calcific uremic arteriolopathy, is a life‐threatening complication of end stage renal disease.
Treatment of this condition is multidisciplinary which includes elaborate wound care, increasing dialysis dose, and discontinuing vitamin D supplements and calcium containing phosphate binders.
Even though STS has been recommended off‐label, several studies have shown promising results with resolution of lesions.
Thus, sodium thiosulfate has become the mainstay of treatment.
Parathyroidectomy is a recommended modality of treatment in those with high PTH levels.
Our case was unique in that calciphylaxis developed after subtotal parathyroidectomy.
We believe that this is due to a decreased PTH level and decreasing bone turnover which resulted in more circulating calcium facilitating vascular and soft tissue calcification.
The exact mechanism of developing calciphylaxis after parathyroidectomy is unknown.
Even though parathyroidectomy is an effective treatment for calciphylaxis, clinicians should be aware that it can rarely present after parathyroidectomy.
Related Results
Potential effect of sodium thiosulfate in calciphylaxis: remission of intractable pain
Potential effect of sodium thiosulfate in calciphylaxis: remission of intractable pain
Abstract
Calciphylaxis, a rare disease mainly seen in patients with chronic kidney disease, is characterised by ischaemic skin damages and excruciating pain. Calciphylaxis ha...
A Case of Calciphylaxis
A Case of Calciphylaxis
Introduction: Calciphylaxis (calcific uremic arteriolopathy), is a condition primarily observed in patients with end-stage renal disease (ESRD).
Aim: To increase clinical awareness...
Pain Management in Calciphylaxis
Pain Management in Calciphylaxis
Pain management in calciphylaxis is challenging due to the complex etiology of pain. Effective pain control requires multimodal treatment to limit further ischemic damage by inhibi...
Recurrent urolithiasis following parathyroidectomy for primary hyperparathyroidism
Recurrent urolithiasis following parathyroidectomy for primary hyperparathyroidism
Introduction The effect of parathyroidectomy on the incidence of recurrent stone formation is uncertain. We aimed to compare the biochemistry and recurrence rate of urolithiasis in...
Radioactive probe-guided parathyroidectomy for secondary hyperparathyroidism
Radioactive probe-guided parathyroidectomy for secondary hyperparathyroidism
Background
The value of gamma probes in the surgical treatment of secondary hyperparathyroidism (sHPT) was determined. The aim of this study was to enhance the rate of ...
Surgical Management of Primary Hyperparathyroidism in Older Adults
Surgical Management of Primary Hyperparathyroidism in Older Adults
ObjectivesTo compare the feasibility, safety, and outcome of parathyroidectomy in the management of primary hyperparathyroidism (PHPT) in individuals aged 75 and older with that of...
Complications and Cure Rates of Parathyroidectomy for Primary Hyperparathyroidism with Negative Localization Studies
Complications and Cure Rates of Parathyroidectomy for Primary Hyperparathyroidism with Negative Localization Studies
Purpose: This paper evaluates the outcomes of parathyroidectomy for primary hyperparathyroidism with
negative localization studies.
Methods: All patients with primary hyperparathyr...
Use of four-dimensional computed tomography to aid parathyroid localisation in primary hyperparathyroidism in British surgical practice
Use of four-dimensional computed tomography to aid parathyroid localisation in primary hyperparathyroidism in British surgical practice
Introduction
Four-dimensional computed tomography (4DCT) has emerged as an effective imaging modality to aid parathyroid localisation before surgery. Following ...

